Posted inClinical Updates Gastroenterology news
Optimizing MASH Management: Synergistic Effects of Resmetirom, GLP-1 Receptor Agonists, and Weight Loss in the MAESTRO-NASH Secondary Analysis
This review synthesizes findings from the MAESTRO-NASH trial, highlighting that Resmetirom's efficacy is maintained alongside GLP-1 RAs and SGLT2 inhibitors, while being significantly enhanced by concurrent weight loss.